AVR Anteris Technologies Global Corp.

8-K Current Report

Filed: March 3, 2026

Health Care

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Anteris Technologies Global Corp. Overview

Anteris Technologies Global Corp. (AVR) 8-K current report filed with SEC EDGAR on March 3, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 5.02: Departure/Election of Directors or Officers

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

• CFO Matthew McDonnell awarded supplemental RSU grant valued at $500,000, with share count set by March 4, 2026 closing price
• Vesting schedule: equal one-third tranches on each of first three anniversaries of grant date, requiring continuous employment

+3 more insights

Other Anteris Technologies Global Corp. 8-K Filings

8-K Feb 27, 2026

8-K Dec 15, 2025

Get deeper insights on Anteris Technologies Global Corp.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.